Automated Endoscopy Reprocessor Market - Size, Share, Trends, and Forecast, 2022 - 2028

Automated Endoscopy Reprocessor Market - Size, Share, Trends, and Forecast, 2022 - 2028

Automated Endoscopy Reprocessor (AER) can enhance consistency, efficiency, and reliability of endoscope reprocessing by automating and standardizing various important reprocessing stages, eventually reducing the possibility of human error. AERs reduces exposure to harmful chemical germicides and can decrease health problems related to endoscopes reprocessing. Therefore, American Society for Gastrointestinal Endoscopy (ASGE) strongly recommends the use of AERs for endoscope reprocessing. The World Gastroenterology Organization (WGO) recommends the use of AER as the most extensive options for diagnostics improvement where sufficient resources are available. However, it also states that conversion from manual use to AERs, can generate cost and revenue offsets to produce direct financial gains for some endoscopy units in emerging economies.
Market Dynamics
Major factors driving growth of the automated endoscopy reprocessor market includes rising adoption of AERs in hospitals for infection control and prevention coupled with increasing rate of gastrointestinal disorders. According to Center for Disease Control and Prevention report of 2016, the number of adults diagnosed with ulcers were 14.7 million in the U.S. Furthermore, increasing number of endoscopy procedures and demand for minimally invasive surgeries due low hospital stay cost is also expected to fuel automated endoscope reprocessor market growth. However, risk of infection post endoscopic reprocessing procedures and complications related with AERs can negatively impact adoption of automated endoscope reprocessors, thus affecting growth of the market during the forecast period. Product recalls due to stringent government regulations is also a major factor hindering the market growth.
Key features of the study:

This report provides in-depth analysis of automated endoscopy reprocessor market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global automated endoscopy reprocessor market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Cantel Medical Corp., Johnson & Johnson, Laboratoires Anios, Olympus Corporation, Steelco SpA, Steris Plc., Getinge Group, Hoya Group, and Metall Zug AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global automated endoscopy reprocessor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the automated endoscopy reprocessor market

Detailed Segmentation:

Global Automated Endoscopy Reprocessor Market, By Product Type:

Single Basin
Double Basin

Global Automated Endoscopy Reprocessor Market, By Modality:

Portable
Standalone

Global Automated Endoscopy Reprocessor Market, By End User:

Hospital
Diagnostics Laboratories
Ambulatory Centers

Global Automated Endoscopy Reprocessor Market, By Geography:

North America

By Product Type:

Single Basin
Double Basin

By Modality:

Portable
Standalone

By End User:

Hospital
Diagnostics Laboratories
Ambulatory Centers

By Country:

U.S.
Canada

Latin America

By Product Type:

Single Basin
Double Basin

By Modality:

Portable
Standalone

By End User:

Hospital
Diagnostics Laboratories
Ambulatory Centers

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Product Type:

Single Basin
Double Basin

By Modality:

Portable
Standalone

By End User:

Hospital
Diagnostics Laboratories
Ambulatory Centers

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Product Type:

Single Basin
Double Basin

By Modality:

Portable
Standalone

By End User:

Hospital
Diagnostics Laboratories
Ambulatory Centers

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Product Type:

Single Basin
Double Basin

By Modality:

Portable
Standalone

By End User:

Hospital
Diagnostics Laboratories
Ambulatory Centers

By Country:

GCC
Israel
Rest of Middle East

Africa

By Product Type:

Single Basin
Double Basin

By Modality:

Portable
Standalone

By End User:

Hospital
Diagnostics Laboratories
Ambulatory Centers

By Country:

North Africa
South Africa
Central Africa

Company Profiles

Cantel Medical Corp.*

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategy

Steris Plc.
Olympus Corporation
Johnson & Johnson
Steelco SpA
Getinge Group
Hoya Group
Metall Zug AG
Laboratoires Anios

“*” marked represents similar segmentation in other categories in the respective section.